Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Vella

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|December 14, 2002
Time to act: global apathy towards HIV/AIDS is a crime against humanityRobert Hogg, Pedro Cahn, Elly T Katabira, et al.
BMC Biotechnology|September 7, 2019
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activityMichela Flego, Aldo Frau, Luisa Accardi, et al.
BMC Public Health|December 3, 2024
The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in EthiopiaAbel Gedefaw, Birkneh Tilahun Tadesse, Sintayehu Tadesse, et al.
Journal of Medical Microbiology|December 17, 2008
Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptionsLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 7, 2011
Limited risk of drug resistance after discontinuation of antiretroviral prophylaxis for the prevention of breastfeeding transmission of HIVLeonardo Palombi, Richard Luhanga, Clementina Galluzzo, et al.
Journal of Medical Virology|February 11, 2018
Antibody response to hepatitis B vaccine in HIV-exposed infants in Malawi and correlation with HBV infection acquisitionSandro Mancinelli, Maria F Pirillo, Giuseppe Liotta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 25, 2008
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapyLucia Palmisano, Marina Giuliano, Flavia Chiarotti, et al.
AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.
AIDS (London, England)|October 18, 2005
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapyLucia Palmisano, Marina Giuliano, Emanuele Nicastri, et al.
AIDS (London, England)|July 11, 2008
Single-nucleotide polymorphisms in human beta-defensin-1 gene in Mozambican HIV-1-infected women and correlation with virologic parametersSilvia Baroncelli, Elisabetta Ricci, Mauro Andreotti, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|December 14, 2002
Time to act: global apathy towards HIV/AIDS is a crime against humanityRobert Hogg, Pedro Cahn, Elly T Katabira, et al.
BMC Biotechnology|September 7, 2019
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activityMichela Flego, Aldo Frau, Luisa Accardi, et al.
BMC Public Health|December 3, 2024
The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in EthiopiaAbel Gedefaw, Birkneh Tilahun Tadesse, Sintayehu Tadesse, et al.
Journal of Medical Microbiology|December 17, 2008
Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptionsLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 7, 2011
Limited risk of drug resistance after discontinuation of antiretroviral prophylaxis for the prevention of breastfeeding transmission of HIVLeonardo Palombi, Richard Luhanga, Clementina Galluzzo, et al.
Journal of Medical Virology|February 11, 2018
Antibody response to hepatitis B vaccine in HIV-exposed infants in Malawi and correlation with HBV infection acquisitionSandro Mancinelli, Maria F Pirillo, Giuseppe Liotta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 25, 2008
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapyLucia Palmisano, Marina Giuliano, Flavia Chiarotti, et al.
AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.
AIDS (London, England)|October 18, 2005
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapyLucia Palmisano, Marina Giuliano, Emanuele Nicastri, et al.
AIDS (London, England)|July 11, 2008
Single-nucleotide polymorphisms in human beta-defensin-1 gene in Mozambican HIV-1-infected women and correlation with virologic parametersSilvia Baroncelli, Elisabetta Ricci, Mauro Andreotti, et al.
Pageof 16